Written question asked by Lord Clement-Jones (Liberal Democrat), in the House of Lords. It was due for an answer on Thursday, 1 May 2003. It was answered by Baroness Andrews (Labour) on Thursday, 1 May 2003.
Andrews, Baroness
- Question
- Whether they will invest to prevent up to 70,000 transfusion patients each year from continuing to be put at risk from United Kingdom-sourced, non-virally inactivated transfusion plasma; and in the light of the £88 million spent to secure safer products for haemophiliacs, and the £55 million to secure the supply of United States-sourced plasma for certain patients, whether they will consider an additional £9.6 million to supply a United States-sourced, virally-inactivated transfusion plasma for the 70,000 patients who undergo plasma transfusions each year. [HL 2553] [HL 2555].
Secondary information
- Type
- Written question
- Reference
- HL 2553; 647 c126-7WA
- Session
- 2002-03
- Subjects
- Contamination Blood Patients Protection USA Viral diseases Blood transfusions CJD
Librarians' tools
- Timestamp
- 2013-11-25 07:30:12 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_812534
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_812534
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_812534